Share
 
Title
Code
Session Type
Track
Format
CME accreditation
ROOM/CHANNEL
Date Time
Moderator
10:30
2 min
Introduction
Esper KALLAS, University of São Paulo, Brazil
10:32
8 min
Potent latency reversal enables in-depth transcriptomic analyses of the HIV reservoir
Marion PARDONS, HIV Cure Research Center, Belgium
Abstract
10:40
8 min
In vivo preclinical efficacy of MGD014 and MGD020 (HIV-1 envelope x CD3 DART molecules) and first-in-human phase 1 clinical safety evaluation of MGD014
Jeffrey NORDSTROM, MacroGenics Inc, United States
Abstract
10:48
8 min
AZD5582 and SIV Env-targeting rhesus monoclonal antibodies (RhmAbs) ± N-803 in SIV-infected ART-suppressed rhesus macaques
Amir DASHTI, Emory University, United States
Abstract
10:56
8 min
Temsavir treatment of HIV-1-infected cells decreases envelope glycoproteins recognition by broadly-neutralizing antibodies
Marianne BOUTIN, Université de Montréal, Canada
Abstract
11:04
26 min
Q&A
Marion PARDONS, HIV Cure Research Center, Belgium
Esper KALLAS, University of São Paulo, Brazil
Jeffrey NORDSTROM, MacroGenics Inc, United States
Amir DASHTI, Emory University, United States
Marianne BOUTIN, Université de Montréal, Canada
AUTHOR
SUMMARY
HIGHLIGHTS
CRITICAL ASSESSMENT